Experts
Stories by Tim Boreham
Experts
CRITERION: Keep it on the downlow but it’s possible successful IPOs are… back?
Experts
CRITERION: Two ASX PFAS success stories? Must be something in the water…
Experts
CRITERION: If reports of Zuckerberg hoarding gooooooold are true… should you?
Experts
Dr Boreham’s Crucible: Universal Biosensors chief John Sharman is exasperated about investor indifference
Experts
CRITERION: Time to get on-board and barrack for Team Tassie stocks? The devil’s in the detail
Health & Biotech
CRITERION: Are profits on the horizon for the ASX’s aged care orphan?
Health & Biotech
Dr Boreham’s Crucible: Vitura Health is the tall poppy in a paddock of weed
Experts
CRITERION: It’s a takeover fire sale on the ASX. These companies are on the specials rack
Experts
Dr Boreham’s Crucible: Does Clinuvel’s investor value run deeper than ‘it just makes Scenesse’?
Experts
CRITERION: Hard rock is so passé; it’s brine’s time in the sun, lithium lovers
Experts